Achieve Life Sciences, Inc. · NASDAQ:ACHV
Logos Global Management LP reported a 8.60% stake in Achieve Life Sciences, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Logos Global Management LP reported a 8.60% stake in Achieve Life Sciences, Inc., 9,702,064 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 8.60%
- Shares
- 9,702,064
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Logos Global Management LP | 8.60% | 9,702,064 |
| Logos Global Management GP LLC | 8.60% | 9,702,064 |
| Logos Global Master Fund LP | 3.80% | 4,200,000 |
| Logos GP LLC | 3.80% | 4,200,000 |
| Logos Opportunities Fund V LP | 4.90% | 5,502,064 |
| Logos Opportunities V GP LLC | 4.90% | 5,502,064 |
| Arsani William | 8.60% | 9,702,064 |
| Graham Walmsley | 4.90% | 5,502,064 |
Source
Download original · View original at SEC
Related
- Achieve Life Sciences, Inc.
- Logos Global Management LP
- Achieve Life Sciences, Inc. shareholders
- Schedule 13G · Logos Global Management LP · Aug 17, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Nov 16, 2026
- Schedule 13G/A · Alyeska Investment Group, L.P. · Nov 16, 2026
- Form 4 · Stewart Richard Alistair · Aug 21, 2026
- Schedule 13G · Janus Henderson Group Ltd. · Aug 13, 2026
- Schedule 13G/A · Franklin Templeton Inc · Jul 28, 2026